About 200 reports

  • INFLUENZA
  • INFLUENZA SYMPTOMS

BMC MEDICINE, ##(##), PP. ##-##.

  • Influenza
  • United States
  • Market Size
  • Sanofi S.A.
  • Seqirus UK Limited
  • Seasonal Influenza: Executive Summary
  • Risk Factors and Comorbidities for Seasonal Influenza

Table ## below outlines the risk factors and comorbidities associated with seasonal influenza.

  • Influenza
  • United Kingdom
  • United States
  • Demographic
  • Social Conditions
  • INFLUENZA SYMPTOMS
  • 4.1.1.1 INFLUENZA A VIRUS

ELSEVIER LTD, ##(##), PP. ##-##.

  • Influenza
  • China
  • East Asia
  • India
  • Sinovac Biotech Ltd.
  • SEASONAL INFLUENZA & VACCINATION
  • 8. Global Influenza Vaccines Market - Driving Factors

Indonesia ##.

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.
  • Seasonal Influenza: Executive Summary
  • Risk Factors and Comorbidities for Seasonal Influenza

Table ## below outlines the risk factors and comorbidities associated with seasonal influenza.

  • Influenza
  • China
  • Japan
  • Demographic
  • Forecast
  • GLOBAL LIVE ATTENUATED INFLUENZA VACCINES MARKET
  • Market definition

GLOBAL RECOMBINANT INFLUENZA VACCINES MARKET Currently, only one recombinant influenza vaccine, Flublok, is approved by the US Food and Drug Administration (FDA) for influenza.

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Seqirus UK Limited
  • Types of human influenza viruses
  • Global influenza POCT market 2016-2021 ($ billions)

Global Influenza Diagnostics Market: About this market Influenza diagnostic kits are available in both rapid and conventional testing models.

  • Diagnostics
  • Influenza
  • World
  • Forecast
  • Seasonal Influenza Key Facts
  • Promising Drugs in Development for Seasonal influenza

Seasonal Influenza: Competitive Landscape to 2026 Report Code: GDHC##CL Published: November 2018 Healthcare TABLE OF CONTENTS ##.

  • Influenza
  • United States
  • Roche Group
  • Sanofi S.A.
  • Shionogi & Co., Ltd.
  • COLD AND FLU DRUGS
  • Cold and Flu Drugs Industry Structure

The Cold and Flu Drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Influenza
  • China
  • Sanshine Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd
  • COLD AND FLU DRUGS
  • COLD AND FLU DRUGS PRODUCER DIRECTORY

The Cold and Flu Drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Influenza
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd
  • COLD AND FLU DRUGS EXPORT (BILLION YUAN)
  • Cold and Flu Drugs Sales Volume by Drugs

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for Cold and Flu Drugs in China is growing rapidly.

  • Influenza
  • China
  • Demand
  • Sanshine Pharmaceutical Co., Ltd.
  • Shineway Pharmaceutical Co., Ltd.

Influenza Market, by Segment, Through 2022 Table ## : European Influenza Market, by Segment, Through 2022 Table ## : Approved WHO Influenza Centers, by Region Table ## : Abbreviations Used in Influenza Markets Table ## : Glossary of Terms Used in

  • Influenza
  • Therapy
  • Vaccine
  • World

Current scientific views on epidemiology and etiology are provided for Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Tuberculosis
  • Europe
  • Japan
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Medical Biotechnology
  • Europe
  • Japan
  • Demand

& nbsp; Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Tuberculosis
  • Europe
  • World
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Medical Biotechnology
  • Europe
  • World
  • Demand
  • 2.2 GLOBAL - NUMBER OF PERSONS VACCINATED WITH INFLUENZA VACCINES AND
  • 5.13 LUXEMBOURG - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

Indonesia ##.

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.

Influenza Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Diagnostics
  • Influenza
  • APAC
  • World
  • Market Size

Influenza Diagnostic Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Diagnostics
  • Influenza
  • APAC
  • World
  • Demand
  • Influenza Vaccines
  • Influenza Drugs

(c) AZOTH Analytics ##.

  • Influenza
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.

Seasonal Influenza Vaccines CONTENTS ## FORECAST: SEASONAL INFLUENZA VACCINES (Published on ## January 2019) ## OVERVIEW ## RECENT FORECAST UPDATES ## MARKET OVERVIEW AND TRENDS ## KEY DRIVERS AND RESISTORS OF CONVERSION TO QIVS ## MARKET DEFINITION AND METHODOLOGY ## US MARKET

  • Influenza
  • Pathology
  • Vaccine
  • European Union
  • United States

2019-2024 USA Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 USA Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis,

  • Influenza
  • Medical Biotechnology
  • United States
  • Forecast
  • Market Shares

2019-2024 Japan Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 Japan Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleo

  • Influenza
  • Medical Biotechnology
  • Japan
  • Forecast
  • Market Shares

2019-2024 UK Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 UK Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, M

  • Influenza
  • Medical Biotechnology
  • United Kingdom
  • Forecast
  • Market Shares

2019-2024 Italy Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 Italy Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleo

  • Influenza
  • Medical Biotechnology
  • Italy
  • Forecast
  • Market Shares

2019-2024 Germany Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 Germany Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononu

  • Influenza
  • Medical Biotechnology
  • Germany
  • Forecast
  • Market Shares

2019-2024 France Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 France Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucl

  • Influenza
  • Medical Biotechnology
  • France
  • Forecast
  • Market Shares

2019-2024 Spain Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 Spain Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleo

  • Influenza
  • Medical Biotechnology
  • Spain
  • Forecast
  • Market Shares

2020 USA Respiratory Disease Testing Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2020 USA Respiratory Disease Testing Market: Shares and Segment Forecasts--Adenovirus, Coronavirus,

  • Infectious Disease
  • Influenza
  • United States
  • Demand
  • Forecast

2020 Japan Respiratory Disease Testing Market Shares: and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2020 Japan Respiratory Disease Testing Market Shares: and Segment Forecasts--Adenovirus, Coronavirus,

  • Influenza
  • Medical Biotechnology
  • Japan
  • Forecast
  • Market Shares